United States In-Situ Hybridization Market Report & Forecast 2021-2027

Publisher Name :
Date: 06-Dec-2021
No. of pages: 90
Inquire Before Buying

United States In-Situ Hybridization Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States In-Situ Hybridization Market Segment Percentages, By Type, 2020 (%)

- Radioactive isotopes

- Non-radioactive labels

United States In-Situ Hybridization Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States In-Situ Hybridization Market Segment Percentages, By Application, 2020 (%)

- Cancer Diagnosis

- Immunology

- Neuroscience

- Cytology

- Infectious Diseases

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In-Situ Hybridization revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies In-Situ Hybridization revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abbott Laboratories

- F. Hoffmann-La Roche

- Leica Biosystems Nussloch

- Agilent Technologies

- Thermo Fisher Scientific

- Merck

- PerkinElmer

- Exiqon A/S

- BioGenex Laboratories

- Advanced Cell Diagnostics

- Bio SB

United States In-Situ Hybridization Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 In-Situ Hybridization Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States In-Situ Hybridization Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States In-Situ Hybridization Overall Market Size
2.1 United States In-Situ Hybridization Market Size: 2021 VS 2027
2.2 United States In-Situ Hybridization Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In-Situ Hybridization Players in United States Market
3.2 Top United States In-Situ Hybridization Companies Ranked by Revenue
3.3 United States In-Situ Hybridization Revenue by Companies
3.4 Top 3 and Top 5 In-Situ Hybridization Companies in United States Market, by Revenue in 2020
3.5 Companies In-Situ Hybridization Product Type
3.6 Tier 1, Tier 2 and Tier 3 In-Situ Hybridization Players in United States Market
3.6.1 List of Tier 1 In-Situ Hybridization Companies in United States
3.6.2 List of Tier 2 and Tier 3 In-Situ Hybridization Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States In-Situ Hybridization Market Size Markets, 2021 & 2027
4.1.2 Radioactive isotopes
4.1.3 Non-radioactive labels
4.2 By Type - United States In-Situ Hybridization Revenue & Forecasts
4.2.1 By Type - United States In-Situ Hybridization Revenue, 2016-2021
4.2.2 By Type - United States In-Situ Hybridization Revenue, 2022-2027
4.2.3 By Type - United States In-Situ Hybridization Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States In-Situ Hybridization Market Size, 2021 & 2027
5.1.2 Cancer Diagnosis
5.1.3 Immunology
5.1.4 Neuroscience
5.1.5 Cytology
5.1.6 Infectious Diseases
5.2 By Application - United States In-Situ Hybridization Revenue & Forecasts
5.2.1 By Application - United States In-Situ Hybridization Revenue, 2016-2021
5.2.2 By Application - United States In-Situ Hybridization Revenue, 2022-2027
5.2.3 By Application - United States In-Situ Hybridization Revenue Market Share, 2016-2027
6 In-Situ Hybridization Companies Profiles
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Details
6.1.2 Abbott Laboratories Business Overview
6.1.3 Abbott Laboratories In-Situ Hybridization Introduction
6.1.4 Abbott Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021)
6.1.5 Abbott Laboratories Recent Developments
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Company Details
6.2.2 F. Hoffmann-La Roche Business Overview
6.2.3 F. Hoffmann-La Roche In-Situ Hybridization Introduction
6.2.4 F. Hoffmann-La Roche In-Situ Hybridization Revenue in United States Market (2016-2021)
6.2.5 F. Hoffmann-La Roche Recent Developments
6.3 Leica Biosystems Nussloch
6.3.1 Leica Biosystems Nussloch Company Details
6.3.2 Leica Biosystems Nussloch Business Overview
6.3.3 Leica Biosystems Nussloch In-Situ Hybridization Introduction
6.3.4 Leica Biosystems Nussloch In-Situ Hybridization Revenue in United States Market (2016-2021)
6.3.5 Leica Biosystems Nussloch Recent Developments
6.4 Agilent Technologies
6.4.1 Agilent Technologies Company Details
6.4.2 Agilent Technologies Business Overview
6.4.3 Agilent Technologies In-Situ Hybridization Introduction
6.4.4 Agilent Technologies In-Situ Hybridization Revenue in United States Market (2016-2021)
6.4.5 Agilent Technologies Recent Developments
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Details
6.5.2 Thermo Fisher Scientific Business Overview
6.5.3 Thermo Fisher Scientific In-Situ Hybridization Introduction
6.5.4 Thermo Fisher Scientific In-Situ Hybridization Revenue in United States Market (2016-2021)
6.5.5 Thermo Fisher Scientific Recent Developments
6.6 Merck
6.6.1 Merck Company Details
6.6.2 Merck Business Overview
6.6.3 Merck In-Situ Hybridization Introduction
6.6.4 Merck In-Situ Hybridization Revenue in United States Market (2016-2021)
6.6.5 Merck Recent Developments
6.7 PerkinElmer
6.7.1 PerkinElmer Company Details
6.7.2 PerkinElmer Business Overview
6.7.3 PerkinElmer In-Situ Hybridization Introduction
6.7.4 PerkinElmer In-Situ Hybridization Revenue in United States Market (2016-2021)
6.7.5 PerkinElmer Recent Developments
6.8 Exiqon A/S
6.8.1 Exiqon A/S Company Details
6.8.2 Exiqon A/S Business Overview
6.8.3 Exiqon A/S In-Situ Hybridization Introduction
6.8.4 Exiqon A/S In-Situ Hybridization Revenue in United States Market (2016-2021)
6.8.5 Exiqon A/S Recent Developments
6.9 BioGenex Laboratories
6.9.1 BioGenex Laboratories Company Details
6.9.2 BioGenex Laboratories Business Overview
6.9.3 BioGenex Laboratories In-Situ Hybridization Introduction
6.9.4 BioGenex Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021)
6.9.5 BioGenex Laboratories Recent Developments
6.10 Advanced Cell Diagnostics
6.10.1 Advanced Cell Diagnostics Company Details
6.10.2 Advanced Cell Diagnostics Business Overview
6.10.3 Advanced Cell Diagnostics In-Situ Hybridization Introduction
6.10.4 Advanced Cell Diagnostics In-Situ Hybridization Revenue in United States Market (2016-2021)
6.10.5 Advanced Cell Diagnostics Recent Developments
6.11 Bio SB
6.11.1 Bio SB Company Details
6.11.2 Bio SB Business Overview
6.11.3 Bio SB In-Situ Hybridization Introduction
6.11.4 Bio SB In-Situ Hybridization Revenue in United States Market (2016-2021)
6.11.5 Bio SB Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. In-Situ Hybridization Market Opportunities & Trends in United States Market
Table 2. In-Situ Hybridization Market Drivers in United States Market
Table 3. In-Situ Hybridization Market Restraints in United States Market
Table 4. Key Players of In-Situ Hybridization in United States Market
Table 5. Top In-Situ Hybridization Players in United States Market, Ranking by Revenue (2019)
Table 6. United States In-Situ Hybridization Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States In-Situ Hybridization Revenue Share by Companies, 2016-2021
Table 8. Companies In-Situ Hybridization Product Type
Table 9. List of Tier 1 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 In-Situ Hybridization Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States In-Situ Hybridization Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States In-Situ Hybridization Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States In-Situ Hybridization Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States In-Situ Hybridization Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States In-Situ Hybridization Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States In-Situ Hybridization Revenue (US$, Mn), 2022-2027
Table 17. Abbott Laboratories Company Details
Table 18. Abbott Laboratories Business Overview
Table 19. Abbott Laboratories In-Situ Hybridization Product
Table 20. Abbott Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abbott Laboratories Recent Developments
Table 22. F. Hoffmann-La Roche Company Details
Table 23. F. Hoffmann-La Roche Business Overview
Table 24. F. Hoffmann-La Roche In-Situ Hybridization Product
Table 25. F. Hoffmann-La Roche In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. F. Hoffmann-La Roche Recent Developments
Table 27. Leica Biosystems Nussloch Company Details
Table 28. Leica Biosystems Nussloch Business Overview
Table 29. Leica Biosystems Nussloch In-Situ Hybridization Product
Table 30. Leica Biosystems Nussloch In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Leica Biosystems Nussloch Recent Developments
Table 32. Agilent Technologies Company Details
Table 33. Agilent Technologies Business Overview
Table 34. Agilent Technologies In-Situ Hybridization Product
Table 35. Agilent Technologies In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Agilent Technologies Recent Developments
Table 37. Thermo Fisher Scientific Company Details
Table 38. Thermo Fisher Scientific Business Overview
Table 39. Thermo Fisher Scientific In-Situ Hybridization Product
Table 40. Thermo Fisher Scientific In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Thermo Fisher Scientific Recent Developments
Table 42. Merck Company Details
Table 43. Merck Business Overview
Table 44. Merck In-Situ Hybridization Product
Table 45. Merck In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Merck Recent Developments
Table 47. PerkinElmer Company Details
Table 48. PerkinElmer Business Overview
Table 49. PerkinElmer In-Situ Hybridization Product
Table 50. PerkinElmer In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. PerkinElmer Recent Developments
Table 52. Exiqon A/S Company Details
Table 53. Exiqon A/S Business Overview
Table 54. Exiqon A/S In-Situ Hybridization Product
Table 55. Exiqon A/S In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Exiqon A/S Recent Developments
Table 57. BioGenex Laboratories Company Details
Table 58. BioGenex Laboratories Business Overview
Table 59. BioGenex Laboratories In-Situ Hybridization Product
Table 60. BioGenex Laboratories In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. BioGenex Laboratories Recent Developments
Table 62. Advanced Cell Diagnostics Company Details
Table 63. Advanced Cell Diagnostics Business Overview
Table 64. Advanced Cell Diagnostics In-Situ Hybridization Product
Table 65. Advanced Cell Diagnostics In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Advanced Cell Diagnostics Recent Developments
Table 67. Bio SB Company Details
Table 68. Bio SB Business Overview
Table 69. Bio SB In-Situ Hybridization Product
Table 70. Bio SB In-Situ Hybridization Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Bio SB Recent Developments
List of Figures
Figure 1. In-Situ Hybridization Segment by Type
Figure 2. In-Situ Hybridization Segment by Application
Figure 3. United States In-Situ Hybridization Market Overview: 2020
Figure 4. United States In-Situ Hybridization Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States In-Situ Hybridization Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by In-Situ Hybridization Revenue in 2020
Figure 7. By Type - United States In-Situ Hybridization Revenue Market Share, 2016-2027
Figure 8. By Application - United States In-Situ Hybridization Revenue Market Share, 2016-2027
Figure 9. Abbott Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. F. Hoffmann-La Roche In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Leica Biosystems Nussloch In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Agilent Technologies In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Thermo Fisher Scientific In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Merck In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. PerkinElmer In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Exiqon A/S In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. BioGenex Laboratories In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Advanced Cell Diagnostics In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Bio SB In-Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs